<?xml version="1.0"?>
<Document>

	<Sentence>
		<value>Lambert-Eaton syndrome is a disorder in which faulty communication between nerves and muscles leads to muscle weakness.</value>
		<pattern_crowdsource> [[Lambert-Eaton syndrome|C0022972]] is a [[disorder|C0012634]] in which faulty communication between nerves and muscles leads to [[muscle weakness|C0151786]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Lambert-Eaton syndrome</surface-form>
				<RDF-ID>C0022972</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disorder</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>faulty</surface-form>
				<RDF-ID>C1280014</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>communication</surface-form>
				<RDF-ID>C0009452</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>nerves</surface-form>
				<RDF-ID>C0027769</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>muscles</surface-form>
				<RDF-ID>C0026845</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>muscle weakness</surface-form>
				<RDF-ID>C0151786</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0022972 ISA C0012634</triple>
			<triple>C0012634 AFFECTS C0151786</triple>
			<triple>C0022972 AFFECTS C0151786</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Lambert-Eaton syndrome is an autoimmune disorder.</value>
		<pattern_crowdsource> [[Lambert-Eaton syndrome|C0022972]] is an [[autoimmune disorder|C0004364]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Lambert-Eaton syndrome</surface-form>
				<RDF-ID>C0022972</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>autoimmune disorder</surface-form>
				<RDF-ID>C0004364</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0022972 ISA C0004364</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>In this syndrome, antibodies produced by the immune system attack nerve cells.</value>
		<pattern_crowdsource> In this syndrome, [[antibodies|C0003241]] produced by the immune system attack [[nerve cells|C0027882]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>syndrome</surface-form>
				<RDF-ID>C0039082</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>antibodies</surface-form>
				<RDF-ID>C0003241</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>immune system</surface-form>
				<RDF-ID>C0020962</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>attack</surface-form>
				<RDF-ID>C0277793</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>nerve cells</surface-form>
				<RDF-ID>C0027882</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0027882 PRODUCES C0003241</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Lambert-Eaton syndrome may occur with cancers such as small cell lung cancer or autoimmune disorders such as vitiligo, which leads to a loss of skin pigment.</value>
		<pattern_crowdsource> [[Lambert-Eaton syndrome|C0022972]] may occur with [[cancers|C0006826]] such as [[small cell lung cancer|C0149925]] or [[autoimmune disorders|C0004364]] such as [[vitiligo|C0042900]], which leads to a loss of skin pigment.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Lambert-Eaton syndrome</surface-form>
				<RDF-ID>C0022972</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>cancers</surface-form>
				<RDF-ID>C0006826</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>small cell lung cancer</surface-form>
				<RDF-ID>C0149925</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>autoimmune disorders</surface-form>
				<RDF-ID>C0004364</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>vitiligo</surface-form>
				<RDF-ID>C0042900</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>loss</surface-form>
				<RDF-ID>C1517945</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>skin</surface-form>
				<RDF-ID>C0037267</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pigment</surface-form>
				<RDF-ID>C0031916</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0149925 ISA C0006826</triple>
			<triple>C0042900 ISA C0004364</triple>
			<triple>C0022972 COEXISTS_WITH C0006826</triple>
			<triple>C0022972 COEXISTS_WITH C0149925</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>The main goals of treatment are to:  - Identify and treat any underlying disorders, such as lung cancer  - Give treatment to help with the weakness   A treatment called plasma exchange or plasmapheresis usually improves symptoms.</value>
		<pattern_crowdsource> The main goals of [[treatment|C0087111]] are to:  - Identify and treat any underlying [[disorders|C0012634]], such as [[lung cancer|C0242379]]  - Give treatment to help with the weakness   A treatment called [[plasma exchange|C0032113]] or [[plasmapheresis|C0032134]] usually improves [[symptoms|C1457887]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>main</surface-form>
				<RDF-ID>C0205225</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>goals</surface-form>
				<RDF-ID>C0018017</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treatment</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disorders</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>lung cancer</surface-form>
				<RDF-ID>C0242379</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treatment</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>weakness</surface-form>
				<RDF-ID>C0004093</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treatment</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>plasma exchange</surface-form>
				<RDF-ID>C0032113</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>plasmapheresis</surface-form>
				<RDF-ID>C0032134</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>symptoms</surface-form>
				<RDF-ID>C1457887</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0242379 ISA C0012634</triple>
			<triple>C0087111 TREATS C0012634</triple>
			<triple>C0032134 TREATS C1457887</triple>
			<triple>C0032113 TREATS C1457887</triple>
			<triple>C0087111 TREATS C0242379</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Medications that suppress the immune response, such as prednisone, may improve symptoms in some cases.</value>
		<pattern_crowdsource> [[Medications|C0013227]] that suppress the [[immune response|C0301872]], such as [[prednisone|C0032952]], may improve [[symptoms|C1457887]] in some cases.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Medications</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>immune response</surface-form>
				<RDF-ID>C0301872</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>prednisone</surface-form>
				<RDF-ID>C0032952</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>symptoms</surface-form>
				<RDF-ID>C1457887</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>cases</surface-form>
				<RDF-ID>C0868928</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0013227 DISRUPTS C0301872</triple>
			<triple>C0032952 TREATS C1457887</triple>
		</triples>
	</Sentence>

</Document>

